UTHR — United Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $11.20bn
- $8.90bn
- $2.33bn
- 98
- 64
- 86
- 96
Annual cashflow statement for United Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -105 | 515 | 476 | 727 | 985 |
| Depreciation | |||||
| Non-Cash Items | 32.9 | 131 | 247 | 165 | 37.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -181 | 59.7 | -174 | -141 | -97.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -207 | 756 | 598 | 803 | 978 |
| Capital Expenditures | -83.7 | -59.3 | -121 | -139 | -230 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -252 | -679 | -366 | -673 | -489 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -335 | -739 | -487 | -812 | -720 |
| Financing Cash Flow Items | -2.8 | -5.4 | -10.8 | -18.9 | -16.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 611 | -16.9 | 44.8 | 75.4 | -11.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 69.2 | 0.3 | 156 | 66.4 | 247 |